Keyword: University of Pennsylvania School of Medicine
A Penn team used gene editing to screen for harmful variants of a gene that causes severe hypertrophic cardiomyopathy.
Recent biotech developments include improved viral delivery vehicles for gene therapy and compounds that cripple resistant bacteria.
PARP inhibitors prevent the misplacement of a specific protein that has been implicated in ALS, new research shows.
Biotech developments over the past week include using circulating RNA to predict preemie births and a new way to free up stiffened heart muscle.
A personalized ovarian cancer vaccine was most effective when given alongside a pair of approved cancer meds.
A new CAR-T approach controlled HIV spread and protected T cells from being attacked by HIV in mouse models.
A synthetic DNA vaccine developed by the Wistar Institute and Penn scientists, with support from Inovio and GeneOne, shows promise in human trials.
The past week brought news of discoveries in neuroblastoma, type 1 diabetes and multiple sclerosis.
A multipronged immune attack that includes CAR-T treatments may be needed to fight glioblastoma, Penn scientists suggest.
This past week ushered in new discoveries in flu prevention, pancreatic cancer and HIV.